About Medcura
Medcura is a company based in United States founded in 2019.. Medcura has raised $87.35 million across 6 funding rounds from investors including TEDCO. Medcura offers products and services including LifeGel and Hemostasis Portfolio. Medcura operates in a competitive market with competitors including Hemotune, ExThera Medical, Lindis Blood Care, CytoPherx and ArtBlood, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$87.35 M (USD)
in 6 rounds
-
Latest Funding Round
$28.55 M (USD), Series C
Apr 16, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medcura
Medcura offers a comprehensive portfolio of products and services, including LifeGel and Hemostasis Portfolio. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Flowable gel for controlling bleeding in surgical procedures
Biopolymer solutions for minimal to moderate bleeding management
Unlock access to complete
Unlock access to complete
Funding Insights of Medcura
Medcura has successfully raised a total of $87.35M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $28.55 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $28.5M
-
First Round
First Round
(21 Sep 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series C - Medcura | Valuation |
investors |
|
| Apr, 2024 | Amount | Series C - Medcura | Valuation |
investors |
|
| Jul, 2022 | Amount | Series C - Medcura | Valuation | TEDCO |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Medcura
Medcura has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TEDCO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Medcura
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Medcura
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medcura Comparisons
Competitors of Medcura
Medcura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, ExThera Medical, Lindis Blood Care, CytoPherx and ArtBlood, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| domain | founded_year | HQ Location |
Innovative solutions for safer blood transfusions are developed.
|
|
| domain | founded_year | HQ Location |
Cytopheresis systems for inflammatory conditions
|
|
| domain | founded_year | HQ Location |
Developer of a cell-based extracorporeal blood production system
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medcura
Frequently Asked Questions about Medcura
When was Medcura founded?
Medcura was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Medcura located?
Medcura is headquartered in United States.
Is Medcura a funded company?
Medcura is a funded company, having raised a total of $87.35M across 6 funding rounds to date. The company's 1st funding round was a Series C of $22.49M, raised on Sep 21, 2020.
What does Medcura do?
Developer of the device for controlling bleeding. The product Triple R is used to rapidly and decisively stop bleeding after diagnostic and interventional vascular access procedures, Life Foam s a self-expanding injectable biopolymer foam to treat internal non-specific hemorrhage, LifeGel for treating bleeding from parenchymal tissue, and Rapid-Seal provides an antibacterial barrier.
Who are the top competitors of Medcura?
Medcura's top competitors include ExThera Medical, Lindis Blood Care and ArtBlood.
What products or services does Medcura offer?
Medcura offers LifeGel and Hemostasis Portfolio.
Who are Medcura's investors?
Medcura has 1 investor. Key investors include TEDCO.